Biotech Already Up Over +300% During Premarket Hours

By: Tomas Ronolski - AllPennyStocks.com News

Tuesday, August 20, 2024

A pharmaceutical company based out of Vancouver is finding an overwhelming amount of success so far during Tuesday’s premarket hours after the company confirmed its INM-901 as an oral formulation that will be utilized in its development programs for Alzheimer's disease.

Shares of InMed Pharmaceuticals Inc. (Nasdaq:INM) rallied strongly on this morning’s announcement, with traders currently willing to buy shares of this micro cap at $0.6851/share (+362.91% implied open for sellers) at the time of writing. Be sure to watch this stock this morning!

InMed Pharmaceuticals Inc is a Canada based pre-clinical stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based therapies combined with drug delivery systems. It is focused on the treatment of diseases including pain and inflammation, dermatology, Orofacial Pain, Glaucoma, ocular, CNS, respiratory, metabolic diseases, and others

Copyright © 2024 AllPennyStocks.com. All rights reserved. Republication or redistribution of AllPennyStocks.com's content is expressly prohibited without the prior written consent of AllPennyStocks.com. AllPennyStocks.com shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Other Penny Stock Movers

Gold Company Notes “Tremendous Potential” at Core Project

Solar Shares Trading Up Over +50% Leading Up To Opening Bell

Small Cap Up Big Following Coverage Initiation And Buy Rating

Canadian Inflation Reaches 40-Month Low

Solar Energy Firm Announces New Project, Sending Shares Higher

Gold Company Notes “Tremendous Potential” at Core Project

PGA Tour Meets With Saudi Fund in New York to Discuss LIV Golf Deal

EU's top court dismisses Apple's final appeal against order to pay Ireland 13B euros in back taxes

AllPennyStocks.com Favorites

Markets Plummet on Weak Economic Data

Enable Free Access to Unlock Up to Two Articles Per Month.

This Outperforming Biotech Could Have A Lot More Room To Run

Enable Free Access to Unlock Up to Two Articles Per Month.

Company Spotlight: Rakovina Therapeutics Inc. (TSX-V:RKV)

Wednesday's technical standout looks to be Modular Medical Inc., which is displaying a Golden Cross (50 DMA / 200 DMA) with today’s move to $2.10.

Trading on the Canadian Securities Exchange, Caprock Mining Corp. rallied 200.00%, closing at $0.02 on Wednesday.

Trading on the OTC Markets, Southport Acquisition Corporation Warrants rallied 1187.13%, closing at $0.13 on Wednesday.

Breaking the Needle: How Tech is Revolutionizing Diabetes Care

Enable Free Access to Unlock Up to Two Articles Per Month.

Double Bottom Alert: This Stock's Chart Pattern Could Lead to Profits

Enable Free Access to Unlock Up to Two Articles Per Month.

WANT TO UNLOCK ACCESS TO:

●Stock Picks

●Penny Stocks to Watch

●Market Commentary

●Watch Lists

And much more by becoming an AllPennyStocks.com Free Member.

Free Membership Has Its Perks!

By entering your email address, you agree to AllPennyStocks.com’s disclaimer and privacy policy.

Register via:

You understand that AllPennyStocks.com and its affiliates may use your address to send updates, ads and offers.

Go Back

Email Registration

By clicking on the "Start Viewing AllPennyStocks.com Pro Articles" button below, you are confirming that you understand and accept that the content we are showing you is not meant to be used as financial advice. This content is merely for educational purposes and shows our readers real-time examples of trading strategies based on technical and fundamental analysis principles, along with stock market commentary.

Investing in stocks is risky stuff, trust us on that one, and past performance may not be indicative of future performance.

We want everyone to enjoy this information for its educational value, and we remind everyone that we are not liable for losses or damages of any kind from trading based on our information. The only thing we will recommend is to consult with a financial advisor prior to making any trades.

With that said, if we're on the same page here and you agree to our disclaimer, click the button below and enjoy all of our AllPennyStocks.com Pro content.

© Copyright 2024 AllPennyStocks.com Media Inc. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes.
Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Data is provided by QuoteMedia.com.

Biotech Already Up Over +300% During Premarket Hours

Other Penny Stock Movers

Gold Company Notes “Tremendous Potential” at Core Project

Solar Shares Trading Up Over +50% Leading Up To Opening Bell

Small Cap Up Big Following Coverage Initiation And Buy Rating

Most Popular

AllPennyStocks.com Favorites